KLEIN LAWRENCE OTTO (President and CEO) sold 7.5% of their position (75K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.89M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/1/2026ACC: 0000907654-26-000087
DirectorOfficer· President and CEO
Since Aug 2024
-75K
Net shares
Net seller
$6.89M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
75K acquired · 150K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+75K
Price / share
$7.80
Trade value
$585K
% of position
8.1%
9/1/2026
925.58K→1M
Common Stock
Direct
Shares
−6.60K
Price / share
$90.79
Trade value
$599.56K
% of position
0.7%
9/1/2026
1M→993.98K
Common Stock
Direct
Shares
−63.60K
Price / share
$91.90
Trade value
$5.84M
% of position
6.4%
9/1/2026
993.98K→930.38K
Common Stock
Direct
Shares
−4.80K
Price / share
$92.44
Trade value
$443.69K
% of position
0.5%
9/1/2026
930.38K→925.58K
Total
Net shares
+0.00
Net value
-$6.30M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | M · Option Exercise | +75K | $7.80 | $585K | 8.1% | 925.58K | 1M |
| Common Stock Direct | 9/1/2026 | S · Sale | −6.60K | $90.79 | $599.56K | 0.7% | 1M | 993.98K |
| Common Stock Direct | 9/1/2026 | S · Sale | −63.60K | $91.90 | $5.84M | 6.4% | 993.98K | 930.38K |
| Common Stock Direct | 9/1/2026 | S · Sale | −4.80K | $92.44 | $443.69K | 0.5% | 930.38K | 925.58K |
| Total | +0.00 | -$6.30M | ||||||
Derivative Transactions1
Employee Warrant (right to buy)
Direct
Converts to
Common Stock
75K shares
Shares
−75K
Strike price
7.8
Held after
1.55M
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock75K shares | 9/1/2026 | M · Option Exercise | −75K | 7.8 | — | 1.55M |